Genome Sequence of Serratia plymuthica A153, a Model Rhizobacterium for the Investigation of the Synthesis and Regulation of Haterumalides, Zeamine, and Andrimid.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Article
Change log
Authors
Matilla, Miguel A
Drew, Alison
Udaondo, Zulema
Salmond, George PC
Abstract
The rhizobacterium Serratia plymuthica A153 is a Gram-negative bacterium belonging to the family Enterobacteriaceae Here, we present the genome sequence of this strain, which produces multiple bioactive secondary metabolites, including the halogenated macrolide oocydin A, the polyamino antibiotic zeamine, and the bacterial acetyl-CoA carboxylase inhibitor andrimid.
Description
Keywords
3107 Microbiology, 31 Biological Sciences, 3105 Genetics, Infectious Diseases
Journal Title
Genome Announc
Conference Name
Journal ISSN
2169-8287
2169-8287
2169-8287
Volume Title
4
Publisher
American Society for Microbiology
Publisher DOI
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/N008081/1)
European Commission (298003)
European Commission (298003)
Work in the Salmond laboratory was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, United Kingdom). Miguel A. Matilla was supported by the EU Marie-Curie intra-European Fellowship For Career Development (FP7-PEOPLE-2011-IEF) grant 298003 and the Spanish Ministry of Economy and Competitiveness Postdoctoral Research Program, Juan de la Cierva (JCI-2012-11815). The Tino Krell laboratory is supported by FEDER funds and Fondo Social Europeo through grants from the Junta de Andalucía (grant CVI-7335) and the Spanish Ministry for Economy and Competitiveness (grants BIO2013- 42297 and RTC-2014-1777-3).